» Authors » Selvi Celik

Selvi Celik

Explore the profile of Selvi Celik including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 160
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Celik S, Hyrefelt L, Czuba T, Li Y, Assis J, Martinez J, et al.
Cardiovasc Res . 2025 Mar; PMID: 40042822
Background: Alternative splicing of Titin (TTN) I-band exons produce protein isoforms with variable size and elasticity, but the mechanisms whereby TTN splice factors regulate exon usage and thereby determining cardiomyocyte...
2.
Linner E, Czuba T, Gidlof O, Lundgren J, Bollano E, Hellberg M, et al.
Sci Rep . 2025 Feb; 15(1):4306. PMID: 39910139
The genetic contributions to early onset heart failure (HF) are incompletely understood. Genetic testing in advanced HF patients undergoing heart transplantation (HTx) may yield clinical benefits, but data is limited....
3.
Pimpalwar N, Celik S, Karbalaei Sadegh M, Czuba T, Gidlof O, Smith J
FASEB J . 2024 Feb; 38(4):e23510. PMID: 38407489
Heart failure (HF) is a leading cause of death and disability globally. Heritable factors and the extent and pattern of myocardial fibrosis are important determinants of outcomes in patients with...
4.
Martinez M, Ritsvall O, Bastrup J, Celik S, Jakobsson G, Daoud F, et al.
JCI Insight . 2023 Aug; 8(17). PMID: 37561588
Inadequate adaption to mechanical forces, including blood pressure, contributes to development of arterial aneurysms. Recent studies have pointed to a mechanoprotective role of YAP and TAZ in vascular smooth muscle...
5.
Celik S, Sadrian J, Grossi M, Czuba T, Lundgren J, Radegran G, et al.
JACC Basic Transl Sci . 2023 Jun; 8(5):439-456. PMID: 37325400
Acute cellular rejection (ACR) is a leading cause of graft loss and death after heart transplantation despite effective immunosuppressive therapies. The identification of factors that impair graft vascular barrier function...
6.
Gidlof O, Bader K, Celik S, Grossi M, Nakagawa S, Hirose T, et al.
Cell Death Dis . 2020 Aug; 11(8):677. PMID: 32826883
While restoration of coronary blood flow to the ischemic heart is the most effective strategy for reducing infarct size, reperfusion injury represents a significant limiting factor on clinical outcomes in...
7.
Egerstedt A, Berntsson J, Smith M, Gidlof O, Nilsson R, Benson M, et al.
Nat Commun . 2019 Dec; 10(1):5830. PMID: 31862877
Heart failure (HF) is a major public health problem characterized by inability of the heart to maintain sufficient output of blood. The systematic characterization of circulating proteins across different stages...
8.
Celik S, Karbalaei-Sadegh M, Radegran G, Smith J, Gidlof O
Mol Cell Biol . 2019 Sep; 39(23). PMID: 31548261
Atrial natriuretic peptide (ANP) represents an attractive therapeutic target in hypertension and heart failure. The biologically active form of ANP is produced by the cardiac serine protease corin, and modulation...
9.
Celik S, Karbalaei Sadegh M, Morley M, Roselli C, Ellinor P, Cappola T, et al.
JCI Insight . 2019 Sep; 4(19). PMID: 31503546
The cardiac hormone atrial natriuretic peptide (ANP) is a central regulator of blood volume and a therapeutic target in hypertension and heart failure. Enhanced ANP activity in such conditions through...
10.
Sukma Dewi I, Celik S, Karlsson A, Hollander Z, Lam K, McManus J, et al.
Cardiovasc Res . 2017 Jan; 113(5):440-452. PMID: 28073833
Aims: Exosome-mediated microRNA transfer is a recently discovered mode of cell-to-cell communication, in which microRNAs act as paracrine molecules, exerting their regulatory effects in recipient cells. T cells and endothelial...